SynthesisOrphanet journal of rare diseases2026

XLA-MTS: a distinct clinical genetic entity characterized by immunodeficiency and neurodevelopmental delay.

Ignacio Ventura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.